Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-09 8:15 pm Purchase |
2023-05-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Prosight Management LP | 2,280,778 5.100% |
2,280,778 (New Position) |
Filing History |
| 2023-02-13 10:15 am Purchase |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
ALKEON CAPITAL MANAGEMENT LLC | 2,399,252 6.100% |
2,399,252 (New Position) |
Filing History |
| 2023-02-10 1:56 pm Sale |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,418,068 7.600% |
-50,876 (-1.47%) |
Filing History |
| 2023-02-09 12:01 pm Sale |
2023-02-09 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 4,016,608 10.148% |
-1,890,671 (-32.01%) |
Filing History |
| 2023-02-06 09:50 am Sale |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Victory Capital Management, Inc. | 3,459 0.010% |
-2,297,773 (-99.85%) |
Filing History |
| 2023-01-20 4:09 pm Purchase |
2023-01-13 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
MILLENNIUM MANAGEMENT LLC | 2,433,850 5.400% |
2,433,850 (New Position) |
Filing History |
| 2022-12-29 4:41 pm Purchase |
2022-12-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
PFIZER INC PFE |
5,376,344 12.000% |
5,376,344 (New Position) |
Filing History |
| 2022-12-27 4:36 pm Sale |
2022-12-22 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 1,787,569 4.500% |
-425,002 (-19.21%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BLACKROCK INC BLK |
799,341 2.000% |
-1,616,006 (-66.91%) |
Filing History |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,468,944 8.800% |
376,726 (+12.18%) |
Filing History |
| 2022-02-11 4:54 pm Sale |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 3,671,522 9.300% |
-1,096,659 (-23.00%) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 5,907,279 14.999% |
454,932 (+8.34%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BLACKROCK INC BLK |
2,415,347 6.100% |
536,439 (+28.55%) |
Filing History |
| 2022-02-02 3:53 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Victory Capital Management, Inc. | 2,301,232 5.840% |
2,301,232 (New Position) |
Filing History |
| 2021-08-12 4:17 pm Sale |
2021-08-10 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,212,571 5.600% |
-254,721 (-10.32%) |
Filing History |
| 2021-03-19 6:06 pm Sale |
2021-03-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,467,292 6.800% |
-298,425 (-10.79%) |
Filing History |
| 2021-02-16 12:07 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,092,218 8.700% |
450,000 (+17.03%) |
Filing History |
| 2021-02-12 6:24 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 4,768,181 13.100% |
4,768,181 (New Position) |
Filing History |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 5,452,347 14.999% |
2,215,014 (+68.42%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BLACKROCK INC BLK |
1,878,908 5.300% |
1,878,908 (New Position) |
Filing History |